logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
delete
arrow
返回
C

C. Chouaïd

centre hospitalier intercommunal de créteil

58H指数
1.0K论文数
1.8W被引数
收录论文 222
发表时间
logo
Tolerance and Efficacy of Targeted Therapies After Immunotherapy for Advanced Non-Small Cell Lung Cancers Harboring Oncogenic Alterations: The GFPC-TOXIMAD Study针对携带致癌基因突变型晚期非小细胞肺癌，在免疫疗法后进行靶向治疗耐受性与有效性的研究：GFPC-TOXIMAD研究
errCurrent Oncology
IF3.4
err2026-08-30
err0
errOAAI
errThomas Pierret; Jean-Bernard Auliac; Charles Ricordel; Catherine Daniel; Jessica Nguyen; Florian Guisier; Aurélie Swalduz; Hubert Curcio; Anne Laure Desage; Laurence Bigay-Game; Eric Huchot; Lionel Falchero; Hélène Doubre; Olivier Bylicki; Christos Chouaïd; Laurent Greillier
err分享
err收藏
Second-line chemotherapy efficacy is not affected by prior exposure to immunotherapy in extensive-disease small-cell lung cancer: results from the ESME French national real-world cohort广泛期小细胞肺癌中，先前接受免疫治疗不影响二线化疗的疗效：来自法国ESME全国真实世界队列的研究结果
errESMO Open
IF8.3
err2026-08-07
err0
errOAAI
errE. Gobbini; M.H. Diallo; C. Clément-Duchene; C. Chouaid; S. Hiret; C. Audigier-Valette; A. Bizieux; D. Debieuvre; X. Quantin; Y. Le Guen; A. Lemoine; L. Falchero; J. Remon-Masip; L. Bosquet; M. Pérol; N. Girard
err分享
err收藏
Preventing infusion-related reactions: the lessons learn with the use of amivantamab预防输注相关反应：使用阿木赞妥单抗的经验教训
errJournal of Thoracic Disease
IF1.9
err2026-04-30
err0
PREAI
errChouaid, Christos; Assie, Jean Baptiste; Auliac, Jean Bernard
err分享
err收藏
Association of sleep-related hypoxemia with survival in patients with non-small cell lung cancer – the NEOSAS-GFPC study group睡眠相关低氧血症与无小细胞肺癌患者生存率的相关性——NEOSAS-GFPC研究小组
errCHEST
IF8.6
err2026-03-09
err0
PREAI
errGrégoire Justeau; Laurent Greillier; Florent Vinas; Lionel Falchero; Olivier Bylicki; Marie Bernardi; Francis Martin; Isabelle Simon; Didier Debieuvre; Chrystèle Locher; Acya Bizieux-Thaminy; Virginie Levrat; Stéphanie Fry; Camille Guguen; Frédéric Goutorbe; Philippe Masson; Franck Soyez; Christos Chouaid; Patrick Saulnier; Frédéric Gagnadoux
err分享
err收藏
Real-world 5-year outcomes with durvalumab after chemoradiotherapy in unresectable stage III NSCLC不可切除的III期NSCLC放化疗后durvalumab的真实世界5年结局
errESMO Open
IF8.3
err2026-02-04
err0
errOAAI
errN. Girard; J. Bar; P. Baas; C. Chouaid; D.C. Christoph; J.K. Field; R. Fietkau; M.C. Garassino; P. Garrido Lopez; V. Gregorc; V.D. Haakensen; T.J.N. Hiltermann; S. Kao; F. McDonald; F. Mornex; M. Moskovitz; S. Peters; S. Siva; B. Solomon; Y. Qiao
err分享
err收藏
Overcoming anti-PD-L1 resistance with anti-PD1 therapy: a case report and putative rationale
errEuropean Journal of Cancer
IF7.1
err2026-01-30
err0
PREAI
errKarim AMRANE; Coline LE MEUR; Christos CHOUAID; Christophe MASSARD; Aurélien MARABELLE
err分享
err收藏
Prediction of survival and outcomes with depth of response at 6 months in metastatic non-small-cell lung cancer patients treated with chemotherapy and immunotherapy combination: SPORE trial接受化疗和免疫疗法联合治疗的转移性非小细胞肺癌患者6个月时的生存和预后深度预测: SPORE试验
errESMO Open
IF8.3
err2026-01-29
err0
errOAAI
errF. Moinard-Butot; J.-B. Barbe-Richaud; J. Lasvergnas; J. Ancel; G. Justeau; H. Le Floch; L. Somme; C. Chouaid; O. Bylicki; R. Schott
err分享
err收藏
Response to the letter of Peng Bai and Jun Zhang on Cost-effectiveness of Adjuvant Alectinib in ALK-positive NSCLC—Considerations for Broader Applicability
errLung Cancer
IF4.4
err2026-01-26
err0
PREAI
errR. Supiot; L. du Manoir de Juaye; C. Chouaid
err分享
err收藏
Reliability of the cumulative illness rating scale for geriatrics for assessing multimorbidity in older patients with cancer: results from the ELCAPA cohort
errAGE AND AGEING
IF7.1
err2026-01-01
err0
PREAI
errBenderra, Marc A.; Caillet, Philippe; Aregui, Amelie; Frelaut, Maxime; Boudou-Rouquette, Pascaline; Chouaid, Christos; Bringuier, Michael; Cudennec, Tristan; Paillaud, Elena; Canoui-Poitrine, Florence
err分享
err收藏
Prognostic factors and outcomes of patients with advanced non-small-cell lung cancer treated with osimertinib: a retrospective database study
errESMO Real World Data and Digital Oncology
IF0
err2025-12-01
err1
errOAAI
errPerol, M.; Chouaid, C.; Macouillard, P.; Bosquet, L.; Knott, C.; Jose, S.; Edwards, J.; Luccarini, I.; Sermon, J.; Perualila, N. J.; Diels, J.; Penton, J.; Bjerrum, A.
err分享
err收藏
Management of advanced non-small cell lung cancer with MET-exon-14-skipping alterations: challenges remain after the Chrysalis studyMET外显子14跳跃突变型晚期非小细胞肺癌的管理：Chrysalis研究之后仍面临挑战
errJOURNAL OF THORACIC DISEASE
IF1.9
err2025-11-30
err0
PREAI
errChouaid, Christos; Assie, Jean-Baptiste; Auliac, Jean-Bernard
err分享
err收藏
Evolving Therapeutic Landscape of ROS1-Positive Non-Small Cell Lung Cancer: An Updated ReviewROS1阳性非小细胞肺癌的演变治疗格局：一项更新综述
errCurrent Oncology 2025, Vol. 32, Page 626
IF3.4
err2025-11-06
err0
errOAAI
errHervé Bischoff; Sébastien Gendarme; Laura Somme; Christos Chouaid; Roland Schott
err分享
err收藏
Subcutaneous versus intravenous routes in oncology: Preferences and impacts for patients and healthcare professionals皮下与静脉途径在肿瘤学中的应用：患者与医疗专业人员的选择及影响
errBULLETIN DU CANCER
IF0.8
err2025-11-01
err0
errOAAI
errMir, Sarah; Desroziers, Katia; Saget, Sarah; Gherardi, Alexandre; Groenez, Amandine; Paolantonacci, Julie; Regin, Anne-Cecile; Yahia, Bechir Ben Hadj; Esnault, Cyril; Chouaid, Christos
err分享
err收藏
Response to the letter of Mehmet Mutlu Çatlı, Arif Hakan Önder对Mehmet Mutlu Çatlı, Arif Hakan Önder来信的回复
errClinical Lung Cancer
IF3.3
err2025-10-21
err0
PREAI
errBronstein A; Bylicki O; Chouaïd C
err分享
err收藏
Comorbidities in Lung Cancer Screening: A Key to Finding the Right Spot or Opening Pandora’s Box?肺癌筛查中的合并症：寻找正确途径的关键，还是打开潘多拉魔盒？
errJournal of Thoracic Oncology
IF20.8
err2025-10-03
err0
PREAI
errSebastien Gendarme; Christos Chouaid; Edwin Ostrin
err分享
err收藏
Real-world efficacy and safety of amivantamab in EGFR exon-20-mutant non-small cell lung cancer in a French early-access program: Amexon 20 GFPC study法国早期准入项目中阿曼曲单抗在EGFR外显子20突变非小细胞肺癌中的真实世界有效性与安全性：Amexon 20 GFPC研究
errLung Cancer
IF4.4
err2025-09-26
err0
PREAI
errThomas Pierret; Laurent Greillier; Florian Guisier; Catherine Daniel; Renaud Descourt; Loick Galland; Olivier Molinier; Chantal Decroisette; Alexis Cortot; Diane Moreau; Laurence Bigay Gamé; Marie Wislez; Nicolas Cloarec; Hubert Curcio; Nicolas Delberghe; Jacques Cadranel; Boris Duchemann; Anne Claire Toffart; Christos Chouaïd; Jean-Bernard Auliac
err分享
err收藏
Re-biopsy Feasibility and Clinical Impact on Metastatic Non-Small-Cell Lung Cancer with EGFR/ALK/ROS Oncogenic Driver Progression after Optimal Targeted Therapy: A Multicenter Real-World Analysis再次活检的可行性及在EGFR/ALK/ROS致癌驱动基因进展的转移性非小细胞肺癌经最佳靶向治疗后：一项多中心真实世界分析
errClinical Lung Cancer
IF3.3
err2025-08-21
err0
PREAI
errAntoine Bronstein; Hubert Curcio; Isabelle Monnet; Charles Ricordel; Laurence Bigay-Game; Margaux Geier; Chantal Decroisette; Catherine Daniel; Florian Guisier; Aurélie Swalduz; Anne Claire Toffart; Hélène Doubre; Jean Michel Peloni; Dominique Arpin; Hugues Morel; Remi Veillon; Benedicte Clarisse; Christos Chouaïd; Laurent Greillier; Olivier Bylicki
err分享
err收藏
Alectinib Efficacy Post-Brigatinib Against Advanced ALK+ Non-Small Cell Lung Cancer (BrigALK2-GFPC 02-2019 Study)阿来替尼在布加替尼后对晚期ALK+非小细胞肺癌的疗效（BrigALK2-GFPC 02-2019研究）
errlung cancer targets and therapy
IF0
err2025-08-12
err0
errOAAI
errRenaud Descourt; Florian Guisier; Maurice Pérol; Jacques Cadranel; Helene Doubre; Michael Duruisseaux; Stéphane Culine; Bertrand Mennecier; Olivier Bylicki; Christos Chouaid; Laurent Greillier
err分享
err收藏
Efficacy of first-line treatments for advanced pulmonary sarcomatoid carcinomas: a real-world analysis晚期肺肉瘤样癌一线治疗方案的有效性：一项真实世界分析
errESMO Open
IF8.3
err2025-07-23
err0
PREAI
errK. Amrane; B. Cabarrou; G. Justeau; S. Schneider; X. Quantin; L. Falchero; F. Bigot; V. Ferrari; F. Guisier; N. Girard; H. Lena; E. Dansin; A. Madroszyk; A. Bizieux; D. Debieuvre; M. Perol; Y. Simoneau; L. Bosquet; R. Descourt; C. Chouaïd
err分享
err收藏
Real-world frontline treatments in patients with advanced non-small-cell lung cancer harboring epidermal growth factor receptor exon 20 insertions and adjusted comparisons versus amivantamab plus chemotherapy from the PAPILLON study真实世界中，携带表皮生长因子受体外显子20插入突变的晚期非小细胞肺癌患者的前线治疗方案，以及PAPILLON研究中与阿曼曲单抗联合化疗的调整后比较。
errLUNG CANCER
IF4.4
err2025-05-01
err0
PREAI
errChouaid, Christos; Bosquet, Lise; Knott, Craig; Li, Ziming; Schaeffer, Marcy; Lin, Xiwu; Schioppa, Claudio A.; Perualila, Nolen Joy; Diels, Joris; Caparros, Eduardo Quintero; Galea, Francesca; Hulten, Annika; Greystoke, Alastair
err分享
err收藏

研究方向

暂时未获取到该数据
合作学者
合作期刊
J
Jean‐Yves Blay
H 指数: 158 · 论文数: 2.4K
C
Caroline Robert
H 指数: 154 · 论文数: 1.5K
L
Luis Paz‐Ares
H 指数: 116 · 论文数: 1.4K
E
Egbert F. Smit
H 指数: 113 · 论文数: 1.2K
S
Solange Peters
H 指数: 112 · 论文数: 937
查看更多